Mohsen Saroughi | Machine Learning | Best Scholar Award

Posted on by sciencefather

Mr. Mohsen Saroughi | Machine Learning | Best Scholar Award

Researcher | university of tehran | Iran

Mohsen Saroughi is an accomplished water resource management professional with a passion for research and innovation. With expertise in machine learning, groundwater modeling, and hydrology, Mohsen has established himself as a leading figure in applying artificial intelligence and optimization techniques to water resource challenges.

Profile

Google scholar

Education 🎓

  • Master’s in Water Resource Management (2018–2021): University of Tehran, Tehran, Iran (CGPA: 3.5/4)
  • Bachelor’s in Water Engineering (2014–2018): University of Bu-Ali Sina, Hamedan, Iran (CGPA: 3.1/4)

Experience 💼

Mohsen has served as a teaching assistant and research mentor, guiding students on projects in hydrology and groundwater management. His professional experience includes roles as a language editor, GIS consultant, and intern, where he demonstrated expertise in modeling, remote sensing, and IT solutions.

Research Interests 🔬

Mohsen’s research spans groundwater management, machine learning, climate change, and systems dynamics. He excels in applying artificial intelligence to water resource optimization and hydrological modeling.

Publications 📚

“A novel hybrid algorithms for groundwater level prediction”

  • Authors: M Saroughi, E Mirzania, DK Vishwakarma, S Nivesh, KC Panda, …
  • Journal: Iranian Journal of Science and Technology, Transactions of Civil Engineering
  • Year: 2023
  • Citations: 31

“Hybrid COOT-ANN: a novel optimization algorithm for prediction of daily crop reference evapotranspiration in Australia”

  • Authors: E Mirzania, MH Kashani, G Golmohammadi, OR Ibrahim, M Saroughi
  • Journal: Theoretical and Applied Climatology 154 (1), 201-218
  • Year: 2023
  • Citations: 7

“Shannon entropy of performance metrics to choose the best novel hybrid algorithm to predict groundwater level (case study: Tabriz plain, Iran)”

  • Authors: M Saroughi, E Mirzania, M Achite, OM Katipoğlu, M Ehteram
  • Journal: Environmental Monitoring and Assessment 196 (3), 227
  • Year: 2024
  • Citations: 5

“Prediction of monthly groundwater level using a new hybrid intelligent approach in the Tabriz plain, Iran”

  • Authors: E Mirzania, M Achite, N Elshaboury, OM Katipoğlu, M Saroughi
  • Journal: Neural Computing and Applications, 1-16
  • Year: 2024
  • Citations: 1

“Evaluate effect of 126 pre-processing methods on various artificial intelligence models accuracy versus normal mode to predict groundwater level (case study: Hamedan-Bahar …”

  • Authors: M Saroughi, E Mirzania, M Achite, OM Katipoğlu, N Al-Ansari, …
  • Journal: Heliyon 10 (7)
  • Year: 2024
  • Citations: 0

Awards 🏆

  • Ranked 1% in Official Judicial Experts Water Exam (2024)
  • 6th in Iranian University Entrance Master Exam (2018)
  • 2nd in Provincial Chemistry Competition (2012)

Conclusion 🌍

Mohsen Saroughi is a highly competent and accomplished researcher with strengths in advanced modeling, machine learning applications, and groundwater management. His technical expertise, leadership in mentoring students, and significant contributions to both academic literature and practical tools position him as a strong candidate for the Best Researcher Award. To further enhance his impact, expanding his international collaborations and engaging in projects that directly affect societal challenges could bolster his already impressive academic and professional trajectory.

Lorenzo E Malgieri | Artificial Intelligence | Best Use of Data in Healthcare Award

Posted on by sciencefather

Dr. Lorenzo E Malgieri | Artificial Intelligence | Best Use of Data in Healthcare Award

Chief Innovation Officer | CLE | Italy

Dr. Ing. Lorenzo E. Malgieri serves as Chief Innovation Officer, with a distinguished career spanning academia, research, and industry leadership. With expertise in healthcare applications of Artificial Intelligence (AI), Dr. Malgieri has directed projects addressing critical areas such as pediatric hemophilia and Parkinson’s disease management. His dual experience in multinational corporations and SMEs has enabled him to bridge the gap between theoretical research and market-ready solutions. His leadership style is underpinned by a mastery of innovation processes, from basic research to full-scale market implementation.

Profile

Scholar

Education

Dr. Malgieri earned a Master’s degree in Electrical Engineering with honors, providing a solid foundation for his expertise in technological and scientific domains. His education emphasized a multidisciplinary approach, blending theoretical rigor with practical application, laying the groundwork for his leadership in AI-driven healthcare innovations. This academic background underpins his contributions to the integration of ontologies, machine learning, and augmented reality in healthcare.

Professional Experience

With over three decades of experience, Dr. Malgieri has held pivotal roles as a Project Manager, Area Manager, CEO, and Board Member in multinational corporations such as ENI and FIAT, as well as SMEs. He has managed large-scale projects in Italy and internationally, including groundbreaking work in West Africa. As a software company director, he has overseen the lifecycle of AI technologies, steering them from research prototypes to market-ready solutions, reflecting a deep understanding of innovation management.

Research Interests

Dr. Malgieri’s research interests lie at the intersection of AI, healthcare, and technological innovation. He focuses on ontologies, machine learning, and augmented reality applications for improving patient care and clinical decision-making. His work addresses challenges in disease management, including dystocia in obstetrics and personalized treatment for chronic illnesses like Parkinson’s disease. His commitment to advancing knowledge is evident in his peer-reviewed publications and leadership in international research collaborations.

Awards

Dr. Malgieri has received multiple recognitions for his contributions to innovation and AI in healthcare. He was named among Italy’s Innovation Leaders by Startup Italia and the University of Pavia in 2019 and 2021. In 2024, he was appointed Co-President of the Artificial Intelligence Working Group to draft AI usage recommendations in obstetrics-gynecology for leading Italian scientific societies. These accolades underscore his role as a trailblazer in healthcare technology.

Publications

Dr. Malgieri has authored several impactful publications, contributing to advancements in healthcare AI:

Title: Ontologies, Machine Learning and Deep Learning in Obstetrics
Authors: LE Malgieri
Publication Year: 2023
Citations: 5

Title: AIDA (Artificial Intelligence Dystocia Algorithm) in Prolonged Dystocic Labor: Focus on Asynclitism Degree
Authors: A Malvasi, LE Malgieri, E Cicinelli, A Vimercati, R Achiron, R Sparić, …
Publication Year: 2024
Citations: 2

Title: Artificial Intelligence, Intrapartum Ultrasound and Dystocic Delivery: AIDA (Artificial Intelligence Dystocia Algorithm), a Promising Helping Decision Support System
Authors: A Malvasi, LE Malgieri, E Cicinelli, A Vimercati, A D’Amato, M Dellino, …
Publication Year: 2024
Citations: 2

Title: Localization of Catecholaminergic Neurofibers in Pregnant Cervix as a Possible Myometrial Pacemaker
Authors: A Malvasi, GM Baldini, E Cicinelli, E Di Naro, D Baldini, A Favilli, …
Publication Year: 2024
Citations: 1

Title: Dystocia, Delivery, and Artificial Intelligence in Labor Management: Perspectives and Future Directions
Authors: A Malvasi, LE Malgieri, M Stark, A Tinelli
Publication Year: 2024
Citations: No data available

Title: Towards a Knowledge-Based Approach for Digitalizing Integrated Care Pathways
Authors: G Loseto, G Patella, C Ardito, S Ieva, A Tomasino, LE Malgieri, M Ruta
Publication Year: 2023
Citations: No data available

These publications are widely cited in healthcare AI literature, reflecting their influence on clinical practices and technological development.

Conclusion

Dr. Ing. Lorenzo E. Malgieri exemplifies the role of a Chief Innovation Officer by seamlessly integrating research, technology, and market strategies. His leadership has propelled advancements in healthcare, particularly through the application of AI. Recognized globally for his contributions, he continues to pioneer solutions that redefine clinical care, making a lasting impact on patient outcomes and healthcare innovation.

Guangbo Yu | Artificial Intelligence | Best Researcher Award

Posted on by sciencefather

Mr. Guangbo Yu | Artificial Intelligence | Best Researcher Award

Mr .Guangbo  Yu, PhD Student, University of California, United States.

Mr. Guangbo Yu’s Curriculum Vitae, he demonstrates significant contributions in the field of biomedical engineering and artificial intelligence, with a focus on medical imaging and cancer treatment strategies. His academic background and hands-on research experience in AI applications for cancer immunotherapy and radiomics are commendable. Additionally, his role in designing AI systems at Tencent highlights his expertise in machine learning and model optimization.

Profile

google scholar

🎓 Education:

PhD in Biomedical Engineering (Expected 2027)

University of California, Irvine

Specialization: Radiological Science

Advisor: Prof. Zhuoli Zhang

Master’s in Computer Science

University of Southern California (2015–2017)

Bachelor’s in Software Engineering

University of Electronic Science and Technology of China (2011–2015)

🔬 Research Experience:

Graduate Assistant Researcher at UC Irvine (2022–Present)

Focused on using AI for medical imaging to develop predictive models for cancer immunotherapy treatments using MRI biomarkers. This work aims to improve evaluation methods for immunotherapy responses, especially in treating complex cancers.

💼 Professional Experience:

AI Engineer at Tencent QTrade (2020–2022)

Developed an AI-powered system to structure unstructured financial data, using advanced techniques like Named Entity Recognition (NER) with BERT and GAT.

Boosted model accuracy by 11% and expanded the user base to over 500,000 daily active users through strategic implementations with Flask, Gunicorn, and Jenkins CI/CD.

🔍 Research Interests:

Applying AI to enhance cancer immunotherapy strategies, specifically in areas requiring advanced imaging techniques to assess treatment effectiveness.

Citations:

Citations: 12 (all since 2019)

h-index: 2 (a minimum of two papers with at least two citations each)

i10-index: 0 (no papers with 10 or more citations)

📖 Publications and Presentations:

Qtrade AI at SemEval-2022 Task 11: A Unified Framework for Multilingual NER Task

W. Gan, Y. Lin, G. Yu, G. Chen, & Q. Ye. (2022). Association for Computational Linguistics.

Sorafenib Plus Memory-Like Natural Killer Cell Combination Therapy in Hepatocellular Carcinoma

A. Eresen, Y. Pang, Z. Zhang, Q. Hou, Z. Chen, G. Yu, Y. Wang, V. Yaghmai, … (2024). American Journal of Cancer Research, 14(1), 344.*

Dendritic Cell Vaccination Combined with Irreversible Electroporation for Treating Pancreatic Cancer—A Narrative Review

Z. Zhang, G. Yu, A. Eresen, Z. Chen, Z. Yu, V. Yaghmai, Z. Zhang. (2024). Annals of Translational Medicine.

MRI Radiomics to Monitor Therapeutic Outcome of Sorafenib Plus IHA Transcatheter NK Cell Combination Therapy in Hepatocellular Carcinoma

G. Yu, Z. Zhang, A. Eresen, Q. Hou, E. E. Garcia, Z. Yu, N. Abi-Jaoudeh, … (2024). Journal of Translational Medicine, 22(1), 76.*

Predicting and Monitoring Immune Checkpoint Inhibitor Therapy Using Artificial Intelligence in Pancreatic Cancer

G. Yu, Z. Zhang, A. Eresen, Q. Hou, F. Amirrad, S. Webster, S. Nauli, … (2024). International Journal of Molecular Sciences, 25(22), 12038.*

Sorafenib Plus Memory-Like Natural Killer Cell Immunochemotherapy Boosts Treatment Response in Liver Cancer

A. Eresen, Z. Zhang, G. Yu, Q. Hou, Z. Chen, Z. Yu, V. Yaghmai, Z. Zhang. (2024). BMC Cancer, 24(1), 1215.*

Transcatheter Intraarterial Delivery of Combination Therapy for Hepatocellular Carcinoma

Z. Zhang, A. Eresen, G. Yu, K. Liu, Q. Hou, V. Yaghmai. (2024). Journal of Vascular and Interventional Radiology, 35(3), S199.*

Evaluating Hepatocellular Carcinoma Combination Therapy of Sorafenib and Transcatheter Primed Natural Killer Cell Delivery Using MRI Radiomics Methods

G. Yu, A. Eresen, Z. Zhang, K. Liu, Q. Hou, V. Yaghmai. (2024). Journal of Vascular and Interventional Radiology, 35(3), S143–S144.*

Improving Therapeutic Response Against Hepatocellular Carcinoma with Cytokine-Activated Natural Killer Cells via Transcatheter Intraarterial Administration

A. Eresen, Z. Zhang, G. Yu, Q. Hou, N. Abi-Jaoudeh, V. Yaghmai. (2024). Journal of Vascular and Interventional Radiology, 35(3), S152.*

Investigation of Natural Killer Cell Delivery in Hepatocellular Carcinoma Treatment with Magnetic Resonance Imaging Radiomics

K. Liu, G. Yu, Z. Zhang, Q. Hou, V. Yaghmai, A. Eresen. (2024). Journal of Vascular and Interventional Radiology, 35(3), S92.*

MRI Monitoring of Combined Therapy with Transcatheter Arterial Delivery of NK Cells and Systemic Administration of Sorafenib for the Treatment of HCC

Z. Zhang, G. Yu, A. Eresen, Q. Hou, V. Yaghmai, Z. Zhang. (2024). American Journal of Cancer Research, 14(5), 2216.*